✦ LIBER ✦

Studying Therapy Response and Resistance in Mouse Models for BRCA1-Deficient Breast Cancer

✍ Scribed by Ewa Malgorzata Michalak; Jos Jonkers

Publisher: Springer US
Year: 2011
Tongue: English
Weight: 193 KB
Volume: 16
Category: Article
ISSN: 1083-3021
DOI: 10.1007/s10911-011-9199-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Models for predicting BRCA1 and BRCA2 mu

Models for predicting BRCA1 and BRCA2 mutations in Han Chinese familial breast and/or ovarian cancer patients

✍ Nan-Yan Rao; Zhen Hu; Wen-Feng Li; Juan Huang; Zhong-Liang Ma; Bin Zhang; Feng-X 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 337 KB

Adjuvant systemic therapy for breast can

Adjuvant systemic therapy for breast cancer inBRCA1/BRCA2mutation carriers in a population-based study of risk of contralateral breast cancer

✍ Kerryn W. Reding; Jonine L. Bernstein; Bryan M. Langholz; Leslie Bernstein; Robe 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 188 KB

Evidence for further breast cancer susce

Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study

✍ Antonis C. Antoniou; Paul D.P. Pharoah; Greg McMullan; Nickolas E. Day; Bruce A. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 1 views

We used data from a population based series of breast cancer patients to investigate the genetic models that can best explain familial breast cancer not due to the BRCA1 and BRCA2 genes. The data set consisted of 1,484 women diagnosed with breast cancer under age 55 registered in the East Anglia Can

Endocrine response and resistance in bre

Endocrine response and resistance in breast cancer: a role for the transcription factor Fos

✍ Julia M.W. Gee; Peter C. Willsher; Frances S. Kenny; John F.R. Robertson; Sarah 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 109 KB 👁 2 views

We have previously demonstrated that elevated Fos expression may be important in de novo endocrine resistance in breast cancer. However, changes in Fos expression during endocrine response and subsequently on acquisition of resistance are unknown. This study immunocytochemically monitors Fos protein

Noninvasive functional imaging of P-glyc

Noninvasive functional imaging of P-glycoprotein-mediated doxorubicin resistance in a mouse model of hereditary breast cancer to predict response, and assign P-gp inhibitor sensitivity

✍ Fijs W. B. van Leeuwen; Tessa Buckle; Ariena Kersbergen; Sven Rottenberg; Kennet 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 342 KB

A new endocrine therapy strategy for bon

A new endocrine therapy strategy for bone metastasis of breast cancer: The effect of biological response modifiers and 22-oxacarcitriol on animal models

✍ Yuichi Iino; Takao Yokoe; Michio Maemura; Hiroyuki Takei; Jun Horiguchi; Yasuo M 📂 Article 📅 1997 🏛 Springer Japan 🌐 English ⚖ 235 KB